Publication

Genetic Differences in the Immediate Transcriptome Response to Stress Predict Risk-Related Brain Function and Psychiatric Disorders

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Janine Arloth, Max Planck Institute of PsychiatryRyan Bogdan, Washington University in St. LouisPeter Weber, Max Planck Institute of PsychiatryGoar Frishman, German Research Center for Environmental HealthAndreas Menke, Max Planck Institute of PsychiatryKlaus V. Wagner, Max Planck Institute of PsychiatryGeorgia Balsevich, Max Planck Institute of PsychiatryMathias V. Schmidt, Max Planck Institute of PsychiatryNazanin Karbalai, Max Planck Institute of PsychiatryDarina Czamara, Max Planck Institute of PsychiatryAndre Altmann, Stanford UniversityDietrich Trümbach, German Research Center for Environmental HealthWolfgang Wurst, Max Planck Institute of PsychiatryDivya Mehta, Max Planck Institute of PsychiatryManfred Uhr, Max Planck Institute of PsychiatryTorsten Klengel, Emory UniversityAngelika Erhardt, Max Planck Institute of PsychiatryCaitlin E. Carey, Washington University in St. LouisEmily Drabant Conley, 23andMeMajor Depressive Disorder Working Group, Psychiatric Genomics Consortium (PGC)Andreas Ruepp, German Research Center for Environmental HealthBertram Müller-Myhsok, Max Planck Institute of PsychiatryAhmad R. Hariri, Duke UniversityElisabeth Binder, Emory University
Language
  • English
Date
  • 2015-06-03
Publisher
  • Elsevier (Cell Press)
Publication Version
Copyright Statement
  • © 2015 The Authors
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0896-6273
Volume
  • 86
Issue
  • 5
Start Page
  • 1189
End Page
  • 1202
Grant/Funding Information
  • J.A. was supported in part by the NeuroNova gGmbH, A.R.H. by NIH (NIDA R01-DA031579), R.B. by the Klingenstein Third Generation Foundation and McDonnell Center for Systems Neuroscience, and C.E.C. by an NSF pre-doctoral grant (DGE-1143954).
  • This study has received its main financial support from the European Union under European Research Council GA no. 281338 (to E.B.B.).
  • The Duke Neurogenetics Study (DNS) is supported by Duke University and the NIH (NIDA R01-DA033369).
  • It was also supported by the Helmholtz Portfolio Theme ‘Metabolic Dysfunction and Common Disease’, the Helmholtz Portfolio Theme ‘Supercomputing and Modelling for the Human Brain’ (SMHB), and the BMBF through the Integrated Network IntegraMent under the auspices of the e:Med Programme (to W.W.).
Supplemental Material (URL)
Abstract
  • Depression risk is exacerbated by genetic factors and stress exposure; however, the biological mechanisms through which these factors interact to confer depression risk are poorly understood. One putative biological mechanism implicates variability in the ability of cortisol, released in response to stress, to trigger a cascade of adaptive genomic and non-genomic processes through glucocorticoid receptor (GR) activation. Here, we demonstrate that common genetic variants in long-range enhancer elements modulate the immediate transcriptional response to GR activation in human blood cells. These functional genetic variants increase risk for depression and co-heritable psychiatric disorders. Moreover, these risk variants are associated with inappropriate amygdala reactivity, a transdiagnostic psychiatric endophenotype and an important stress hormone response trigger. Network modeling and animal experiments suggest that these genetic differences in GR-induced transcriptional activation may mediate the risk for depression and other psychiatric disorders by altering a network of functionally related stress-sensitive genes in blood and brain.
Author Notes
Keywords
Research Categories
  • Biology, Genetics
  • Biology, Neuroscience
  • Health Sciences, Mental Health

Tools

Relations

In Collection:

Items